These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 12888137)
41. [Immunoinflammatory factors in unstable angina. Possibility of influence of atorvastatin]. Logacheva IV; Kazantseva MO Kardiologiia; 2007; 47(6):15-20. PubMed ID: 18260869 [TBL] [Abstract][Full Text] [Related]
42. [Statin therapy in patients with acute coronary syndrome. "Prove-it" study]. von Schacky C Internist (Berl); 2004 Dec; 45(12):1437-9. PubMed ID: 15448925 [No Abstract] [Full Text] [Related]
43. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention]. Patti G; Pasceri V; Nusca A; Di Sciascio G Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714 [TBL] [Abstract][Full Text] [Related]
44. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994 [TBL] [Abstract][Full Text] [Related]
45. Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. Wiviott SD; Cannon CP; Morrow DA; Ray KK; Pfeffer MA; Braunwald E; J Am Coll Cardiol; 2005 Oct; 46(8):1411-6. PubMed ID: 16226163 [TBL] [Abstract][Full Text] [Related]
46. Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction. Teshima Y; Yufu K; Akioka H; Iwao T; Anan F; Nakagawa M; Yonemochi H; Takahashi N; Hara M; Saikawa T J Cardiol; 2009 Feb; 53(1):58-64. PubMed ID: 19167639 [TBL] [Abstract][Full Text] [Related]
47. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. Olsson AG; Schwartz GG; Szarek M; Sasiela WJ; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A Eur Heart J; 2005 May; 26(9):890-6. PubMed ID: 15764620 [TBL] [Abstract][Full Text] [Related]
48. [Cost-effectiveness of atorvastatin in the early treatment of acute coronary syndromes in Germany based on the MIRACL study]. Lange AP; Szucs TD Med Klin (Munich); 2004 Sep; 99(9):500-5. PubMed ID: 15372179 [TBL] [Abstract][Full Text] [Related]
49. Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench. Shimada K; Miyauchi K; Daida H Circulation; 2004 May; 109(18):e213-4; author reply e213-4. PubMed ID: 15136515 [No Abstract] [Full Text] [Related]
51. Effects of 4 weeks of atorvastatin administration on the antiinflammatory cytokine interleukin-10 in patients with unstable angina. Li JJ; Fang CH Clin Chem; 2005 Sep; 51(9):1735-8. PubMed ID: 16120956 [No Abstract] [Full Text] [Related]
52. [Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure]. Fries R; Böhm M Med Klin (Munich); 2003 Jun; 98(6):326-34. PubMed ID: 12811417 [TBL] [Abstract][Full Text] [Related]
53. STAR VaS--Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Neilipovitz DT; Bryson GL; Taljaard M Can J Anaesth; 2012 Jun; 59(6):527-37. PubMed ID: 22528165 [TBL] [Abstract][Full Text] [Related]
54. [Indications for statin therapy in patients with acute coronary syndrome of ischemic origin]. Raddino R; Della Pina P; Gorga E; Caretta G; Madureri A; Dei Cas L G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):78S-83S. PubMed ID: 21416832 [TBL] [Abstract][Full Text] [Related]
55. Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction. Colivicchi F; Guido V; Tubaro M; Ammirati F; Montefoschi N; Varveri A; Santini M Am J Cardiol; 2002 Oct; 90(8):872-4. PubMed ID: 12372577 [No Abstract] [Full Text] [Related]
56. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359 [TBL] [Abstract][Full Text] [Related]
57. Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients. Rosenson RS; Hislop C; Elliott M; Stasiv Y; Goulder M; Waters D J Am Coll Cardiol; 2010 Sep; 56(14):1079-88. PubMed ID: 20863951 [TBL] [Abstract][Full Text] [Related]
58. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G; Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322 [TBL] [Abstract][Full Text] [Related]
59. [Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation]. Kuznetsova MA; Vaulin NA; Masenko VP; Gratsianskiĭ NA Kardiologiia; 2010; 50(2):21-5. PubMed ID: 20146674 [TBL] [Abstract][Full Text] [Related]
60. The collaborative atorvastatin diabetes study: preliminary results. Owen OG Int J Clin Pract; 2005 Jan; 59(1):121-3. PubMed ID: 15707477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]